Healthcare Sector Stocks
The Healthcare sector has a total of 1057 stocks, with a combined market cap of $9.28 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 50.00.
Market Cap
9.28T
Revenue
4.66T
Profits
185.6B
PE Ratio
50.00
Profit Margin
3.98%
Dividend Yield
0.38%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.09T | 3.48% | 1,489,786 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 624.43B | -0.05% | 3,680,503 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 433.51B | -0.29% | 1,902,191 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 371.23B | 0.42% | 1,650,316 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 322.04B | 1.52% | 2,808,173 | 66.57B |
| 6 | NVS | Novartis AG | 296.43B | -0.04% | 629,301 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 248.99B | 0.22% | 2,792,671 | 61.37B |
| 8 | AMGN | Amgen Inc. | 223.62B | 0.65% | 890,626 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 220.48B | 0.39% | 1,031,728 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 209.18B | -0.21% | 6,332,190 | 50.34B |
| 11 | ABT | Abbott Laboratories | 188.03B | 0.79% | 2,597,985 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 164.44B | -0.44% | 3,428,448 | 30.46B |
| 13 | PFE | Pfizer Inc. | 153.61B | 0.71% | 36,717,638 | 63.70B |
| 14 | DHR | Danaher Corporation | 145.12B | 0.82% | 2,323,761 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 137.95B | 3.08% | 2,039,215 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 132.86B | 0.49% | 4,656,245 | 49.19B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 132.77B | 5.59% | 1,974,563 | 12.59B |
| 18 | SYK | Stryker Corporation | 131.81B | 1.36% | 940,308 | 25.84B |
| 19 | CVS | CVS Health Corporation | 122.31B | -0.07% | 4,333,823 | 412.65B |
| 20 | MDT | Medtronic plc | 113.90B | 2.09% | 3,264,359 | 36.36B |
| 21 | GSK | GSK plc | 106.01B | -2.01% | 2,049,750 | 44.05B |
| 22 | SNY | Sanofi | 104.53B | 0.23% | 2,098,117 | 55.89B |
| 23 | MCK | McKesson Corporation | 102.76B | 1.36% | 469,277 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 89.40B | -0.10% | 520,362 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 85.83B | 0.39% | 315,483 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.53B | 2.82% | 403,702 | 15.53B |
| 27 | CI | The Cigna Group | 73.51B | -1.52% | 688,340 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 73.46B | 2.80% | 12,949,405 | 21.00B |
| 29 | COR | Cencora, Inc. | 61.77B | 1.01% | 754,364 | 332.77B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 56.52B | 0.23% | 2,954,963 | 28.42B |
| 31 | CAH | Cardinal Health, Inc. | 55.62B | 0.47% | 1,311,892 | 250.74B |
| 32 | ARGX | argenx SE | 55.41B | 0.04% | 216,685 | 5.32B |
| 33 | EW | Edwards Lifesciences Corporation | 53.32B | 3.10% | 2,128,324 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 48.63B | 0.94% | 646,173 | 22.48B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 47.33B | 2.41% | 306,361 | 4.55B |
| 36 | HUM | Humana Inc. | 46.37B | 0.30% | 833,050 | 145.68B |
| 37 | NTRA | Natera, Inc. | 46.21B | -0.47% | 1,561,391 | 2.71B |
| 38 | MDLN | Medline Inc. | 44.46B | -4.00% | 5,365,702 | 29.94B |
| 39 | HLN | Haleon plc | 43.91B | -1.05% | 2,475,156 | 14.80B |
| 40 | RVMD | Revolution Medicines, Inc. | 43.76B | -0.49% | 1,093,015 | - |
| 41 | A | Agilent Technologies, Inc. | 41.81B | 1.42% | 942,254 | 7.23B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 41.25B | 0.11% | 2,687,513 | 17.32B |
| 43 | ONC | BeOne Medicines AG | 40.73B | 2.85% | 670,696 | 6.13B |
| 44 | WAT | Waters Corporation | 40.35B | 1.00% | 430,842 | 4.64B |
| 45 | IQV | IQVIA Holdings Inc. | 39.90B | 1.55% | 590,137 | 16.98B |
| 46 | VEEV | Veeva Systems Inc. | 38.12B | 1.81% | 1,071,990 | 3.32B |
| 47 | ALC | Alcon Inc. | 34.62B | 1.39% | 2,150,901 | 10.63B |
| 48 | DXCM | DexCom, Inc. | 33.16B | 3.69% | 3,965,974 | 4.97B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 33.15B | 2.27% | 1,507,380 | 21.27B |
| 50 | RPRX | Royalty Pharma plc | 32.98B | 1.04% | 2,125,698 | 2.54B |
| 51 | CNC | Centene Corporation | 32.82B | 1.02% | 1,707,626 | 180.30B |
| 52 | RMD | ResMed Inc. | 31.70B | 3.70% | 803,614 | 5.65B |
| 53 | ZTS | Zoetis Inc. | 30.82B | 2.64% | 6,222,853 | 9.53B |
| 54 | BIIB | Biogen Inc. | 30.61B | -0.38% | 375,021 | 10.03B |
| 55 | INSM | Insmed Incorporated | 29.34B | 2.48% | 1,998,239 | 1.14B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.12B | -0.71% | 607,021 | 4.80B |
| 57 | ILMN | Illumina, Inc. | 29.02B | 2.26% | 1,177,455 | 4.49B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.80B | 0.54% | 75,130 | 4.13B |
| 59 | PHG | Koninklijke Philips N.V. | 26.32B | 0.58% | 617,106 | 20.18B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.09B | -0.83% | 429,851 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 25.93B | 0.19% | 306,927 | 14.35B |
| 62 | ROIV | Roivant Sciences Ltd. | 25.87B | -1.43% | 4,203,474 | 7.53M |
| 63 | WST | West Pharmaceutical Services, Inc. | 25.02B | 0.42% | 274,193 | 3.33B |
| 64 | INCY | Incyte Corporation | 24.70B | 1.09% | 527,561 | 5.82B |
| 65 | MRNA | Moderna, Inc. | 23.69B | 0.29% | 4,482,444 | 2.23B |
| 66 | BNTX | BioNTech SE | 23.29B | -1.01% | 443,130 | 3.03B |
| 67 | STE | STERIS plc | 23.16B | 0.05% | 369,111 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 22.73B | 0.54% | 843,218 | 1.18B |
| 69 | UTHR | United Therapeutics Corporation | 22.68B | -1.88% | 185,630 | 3.15B |
| 70 | THC | Tenet Healthcare Corporation | 21.03B | -0.37% | 231,910 | 21.81B |
| 71 | VTRS | Viatris Inc. | 18.94B | 0.37% | 6,193,327 | 14.74B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.58B | 0.90% | 1,290,626 | 8.51B |
| 73 | GMAB | Genmab A/S | 18.45B | -1.89% | 1,508,842 | 4.13B |
| 74 | MEDP | Medpace Holdings, Inc. | 16.74B | 1.55% | 96,603 | 2.78B |
| 75 | NBIX | Neurocrine Biosciences, Inc. | 16.72B | 0.68% | 554,072 | 3.37B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.71B | 0.35% | 395,924 | 4.60B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 16.63B | 0.72% | 1,591,199 | 579.96M |
| 78 | ASND | Ascendis Pharma A/S | 16.61B | -1.33% | 179,307 | 998.25M |
| 79 | COO | The Cooper Companies, Inc. | 14.84B | 2.54% | 1,344,692 | 4.23B |
| 80 | SOLV | Solventum Corporation | 14.60B | 3.38% | 598,533 | 8.31B |
| 81 | BAX | Baxter International Inc. | 14.41B | 1.16% | 5,485,897 | 11.47B |
| 82 | BMRN | BioMarin Pharmaceutical Inc. | 13.27B | 7.44% | 2,892,705 | 3.41B |
| 83 | EXEL | Exelixis, Inc. | 13.11B | -2.15% | 1,099,399 | 2.44B |
| 84 | CRL | Charles River Laboratories International, Inc. | 13.04B | 2.13% | 504,047 | 4.00B |
| 85 | RVTY | Revvity, Inc. | 12.97B | 1.37% | 570,389 | 2.91B |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.89B | -1.35% | 1,466,266 | 14.37B |
| 87 | FMS | Fresenius Medical Care AG | 12.88B | 0.21% | 601,387 | 22.19B |
| 88 | PEN | Penumbra, Inc. | 12.85B | 0.50% | 71,282 | 1.50B |
| 89 | ICLR | ICON Public Limited Company | 12.76B | 0.50% | 215,952 | 8.29B |
| 90 | SNN | Smith & Nephew plc | 12.57B | -0.53% | 820,957 | 6.30B |
| 91 | ALGN | Align Technology, Inc. | 12.50B | 1.32% | 293,730 | 4.14B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.48B | 0.79% | 449,343 | 669.50M |
| 93 | EHC | Encompass Health Corporation | 12.37B | 0.14% | 634,273 | 6.21B |
| 94 | CORT | Corcept Therapeutics Incorporated | 12.34B | 3.03% | 614,793 | 830.81M |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.85B | 0.57% | 170,898 | 1.28B |
| 96 | DVA | DaVita Inc. | 11.68B | -0.35% | 378,352 | 14.01B |
| 97 | HALO | Halozyme Therapeutics, Inc. | 11.67B | -0.26% | 2,999,828 | 1.66B |
| 98 | SMMT | Summit Therapeutics Inc. | 11.63B | 4.44% | 2,247,077 | - |
| 99 | AXSM | Axsome Therapeutics, Inc. | 11.49B | 4.95% | 917,507 | 776.57M |
| 100 | GMED | Globus Medical, Inc. | 11.45B | 3.57% | 1,733,227 | 3.14B |
| 101 | ELAN | Elanco Animal Health Incorporated | 11.25B | 1.76% | 16,264,320 | 5.02B |
| 102 | TECH | Bio-Techne Corporation | 11.24B | -0.21% | 2,389,630 | 1.21B |
| 103 | ABVX | ABIVAX Société Anonyme | 11.06B | -2.09% | 557,924 | 5.67M |
| 104 | GKOS | Glaukos Corporation | 10.72B | 1.01% | 342,670 | 612.84M |
| 105 | CYTK | Cytokinetics, Incorporated | 10.67B | 0.01% | 1,240,717 | 67.67M |
| 106 | ENSG | The Ensign Group, Inc. | 10.65B | 0.73% | 164,523 | 5.49B |
| 107 | MOH | Molina Healthcare, Inc. | 10.33B | 0.98% | 155,261 | 42.47B |
| 108 | UHS | Universal Health Services, Inc. | 10.23B | 0.05% | 362,963 | 18.11B |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 10.13B | -0.98% | 1,001,316 | 3.50B |
| 110 | PRAX | Praxis Precision Medicines, Inc. | 10.12B | 0.48% | 206,225 | 7.46M |
| 111 | APGE | Apogee Therapeutics, Inc. | 10.11B | -0.16% | 487,609 | - |
| 112 | TEM | Tempus AI, Inc. | 9.98B | 6.26% | 5,191,341 | 1.43B |
| 113 | PODD | Insulet Corporation | 9.85B | 0.56% | 775,737 | 3.05B |
| 114 | HSIC | Henry Schein, Inc. | 9.84B | 0.15% | 353,415 | 13.60B |
| 115 | KRYS | Krystal Biotech, Inc. | 9.68B | 0.14% | 91,382 | 440.48M |
| 116 | PTGX | Protagonist Therapeutics, Inc. | 9.62B | 1.89% | 281,103 | 281.99M |
| 117 | IONS | Ionis Pharmaceuticals, Inc. | 9.49B | 0.92% | 965,647 | 874.09M |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 9.41B | -0.13% | 107,998 | 2.59B |
| 119 | AVTR | Avantor, Inc. | 9.28B | 0.92% | 3,347,496 | 6.56B |
| 120 | SYRE | Spyre Therapeutics, Inc. | 9.23B | -0.17% | 484,609 | - |
| 121 | RGEN | Repligen Corporation | 9.22B | -0.27% | 417,435 | 785.10M |
| 122 | QGEN | Qiagen N.V. | 9.06B | 3.57% | 1,994,969 | 2.10B |
| 123 | KYMR | Kymera Therapeutics, Inc. | 8.97B | 0.33% | 234,004 | 105.00M |
| 124 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.93B | 0.11% | 1,045,900 | 42.16M |
| 125 | HQY | HealthEquity, Inc. | 8.90B | 1.72% | 334,036 | 1.34B |
| 126 | PCVX | Vaxcyte, Inc. | 8.70B | 0.69% | 583,595 | - |
| 127 | OSCR | Oscar Health, Inc. | 8.64B | 0.43% | 3,982,047 | 15.32B |
| 128 | BRKR | Bruker Corporation | 8.56B | 5.19% | 1,499,715 | 3.50B |
| 129 | ATR | AptarGroup, Inc. | 8.51B | -1.13% | 169,791 | 3.93B |
| 130 | ALKS | Alkermes plc | 8.27B | 0.21% | 792,308 | 1.67B |
| 131 | IMVT | Immunovant, Inc. | 8.16B | -1.08% | 510,273 | - |
| 132 | LQDA | Liquidia Corporation | 8.10B | 0.92% | 963,904 | 288.07M |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.94B | -0.26% | 364,365 | 239.92M |
| 134 | IBRX | ImmunityBio, Inc. | 7.92B | -2.16% | 4,575,347 | 165.79M |
| 135 | TWST | Twist Bioscience Corporation | 7.75B | 6.88% | 1,372,549 | 431.80M |
| 136 | PACS | PACS Group, Inc. | 7.69B | 0.21% | 326,803 | 5.55B |
| 137 | TXG | 10x Genomics, Inc. | 7.62B | 12.40% | 3,449,897 | 616.91M |
| 138 | HNGE | Hinge Health, Inc. | 7.42B | 2.87% | 1,221,456 | 720.06M |
| 139 | HIMS | Hims & Hers Health, Inc. | 7.39B | 1.08% | 7,340,208 | 2.37B |
| 140 | CHE | Chemed Corporation | 7.16B | -0.42% | 75,595 | 2.60B |
| 141 | GRFS | Grifols, S.A. | 7.05B | 1.39% | 196,042 | 8.48B |
| 142 | COGT | Cogent Biosciences, Inc. | 7.03B | -3.02% | 1,081,468 | - |
| 143 | TGTX | TG Therapeutics, Inc. | 6.98B | -1.13% | 1,120,719 | 799.54M |
| 144 | CGON | CG Oncology, Inc. | 6.63B | -0.36% | 394,613 | 6.23M |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.02% | 916,333 | 1.56B |
| 146 | BLTE | Belite Bio, Inc | 6.54B | 1.90% | 81,784 | - |
| 147 | CAI | Caris Life Sciences, Inc. | 6.48B | 0.84% | 2,610,154 | 989.61M |
| 148 | MIRM | Mirum Pharmaceuticals, Inc. | 6.34B | -2.98% | 418,739 | 618.07M |
| 149 | ERAS | Erasca, Inc. | 6.27B | -1.90% | 1,048,622 | - |
| 150 | SRRK | Scholar Rock Holding Corporation | 6.20B | -3.87% | 448,057 | - |
| 151 | PTCT | PTC Therapeutics, Inc. | 6.17B | 0.91% | 313,524 | 1.01B |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 6.15B | 0.28% | 269,770 | 7.50M |
| 153 | ORKA | Oruka Therapeutics, Inc. | 6.15B | 3.16% | 609,994 | - |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 6.11B | 0.28% | 303,198 | 1.90M |
| 155 | RDNT | RadNet, Inc. | 6.05B | 6.27% | 1,149,668 | 2.27B |
| 156 | BLCO | Bausch + Lomb Corporation | 6.01B | 0.30% | 105,382 | 5.32B |
| 157 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.99B | 1.00% | 143,244 | 840.85M |
| 158 | DFTX | Definium Therapeutics, Inc. | 5.89B | -5.01% | 1,230,872 | - |
| 159 | AMRX | Amneal Pharmaceuticals, Inc. | 5.81B | 0.22% | 624,353 | 3.12B |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 5.77B | -1.21% | 118,575 | 290.54M |
| 161 | TVTX | Travere Therapeutics, Inc. | 5.77B | -0.16% | 520,531 | 591.33M |
| 162 | TFX | Teleflex Incorporated | 5.69B | -0.51% | 267,537 | 2.25B |
| 163 | STVN | Stevanato Group S.p.A. | 5.60B | 1.13% | 332,352 | 1.40B |
| 164 | MMED | MiniMed Group, Inc. | 5.47B | -0.56% | 618,607 | 3.10B |
| 165 | SHC | Sotera Health Company | 5.37B | -0.16% | 1,396,765 | 1.22B |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.36B | 0.80% | 846,566 | 1.58B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.18B | 0.04% | 809,287 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.04B | 0.17% | 1,917,369 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.93B | 0.61% | 1,309,228 | - |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.76B | 0.80% | 661,730 | - |
| 171 | WAY | Waystar Holding Corp. | 4.76B | 2.41% | 1,694,441 | 1.21B |
| 172 | BLLN | BillionToOne, Inc. | 4.62B | 4.79% | 670,797 | 397.41M |
| 173 | LFST | LifeStance Health Group, Inc. | 4.59B | 10.89% | 8,245,042 | 1.58B |
| 174 | ICUI | ICU Medical, Inc. | 4.59B | -0.61% | 234,997 | 2.16B |
| 175 | DOCS | Doximity, Inc. | 4.58B | -6.20% | 7,359,880 | 655.57M |
| 176 | INDV | Indivior Pharmaceuticals, Inc. | 4.57B | -0.21% | 1,076,200 | 1.33B |
| 177 | NVST | Envista Holdings Corporation | 4.53B | 0.27% | 1,699,737 | 2.86B |
| 178 | MANE | Veradermics, Incorporated | 4.51B | -5.64% | 334,733 | - |
| 179 | PBLS | Parabilis Medicines, Inc. | 4.49B | 0.86% | 275,604 | - |
| 180 | CELC | Celcuity Inc. | 4.42B | -2.20% | 249,550 | - |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.38B | 1.01% | 1,695,534 | 10.35M |
| 182 | ELVN | Enliven Therapeutics, Inc. | 4.32B | -2.44% | 314,304 | - |
| 183 | CON | Concentra Group Holdings Parent, Inc. | 4.30B | -1.09% | 484,654 | 2.29B |
| 184 | ITGR | Integer Holdings Corporation | 4.25B | -0.13% | 407,696 | 1.84B |
| 185 | LIVN | LivaNova PLC | 4.20B | -0.05% | 249,313 | 1.47B |
| 186 | IRTC | iRhythm Holdings, Inc. | 4.12B | -2.25% | 580,196 | 825.34M |
| 187 | ADPT | Adaptive Biotechnologies Corporation | 4.12B | 3.45% | 1,572,852 | 308.08M |
| 188 | TLX | Telix Pharmaceuticals Limited | 3.99B | 2.43% | 58,758 | 803.79M |
| 189 | LEGN | Legend Biotech Corporation | 3.99B | -0.63% | 1,560,696 | 1.14B |
| 190 | VKTX | Viking Therapeutics, Inc. | 3.98B | -0.53% | 1,078,381 | - |
| 191 | HAE | Haemonetics Corporation | 3.94B | -1.33% | 258,281 | 1.35B |
| 192 | TNGX | Tango Therapeutics, Inc. | 3.93B | 0.41% | 1,284,434 | 56.99M |
| 193 | DNLI | Denali Therapeutics Inc. | 3.92B | -0.60% | 786,574 | 3.60M |
| 194 | GPCR | Structure Therapeutics Inc. | 3.76B | -0.32% | 218,996 | - |
| 195 | VCYT | Veracyte, Inc. | 3.72B | -2.08% | 352,686 | 561.90M |
| 196 | OPCH | Option Care Health, Inc. | 3.66B | 2.65% | 1,249,303 | 5.69B |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.66B | 0.31% | 498,978 | 117.00M |
| 198 | OGN | Organon & Co. | 3.58B | 0.18% | 813,406 | 6.13B |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.53B | -1.19% | 384,894 | 234.13M |
| 200 | ALMS | Alumis Inc. | 3.50B | -0.43% | 229,263 | 8.40M |
| 201 | NHC | National HealthCare Corporation | 3.42B | 1.33% | 88,902 | 1.56B |
| 202 | CLDX | Celldex Therapeutics, Inc. | 3.34B | 1.99% | 411,919 | 158.00K |
| 203 | NAMS | NewAmsterdam Pharma Company N.V. | 3.34B | -0.11% | 528,619 | 7.12M |
| 204 | GRAL | GRAIL, Inc. | 3.28B | 5.66% | 689,734 | 165.26M |
| 205 | BKD | Brookdale Senior Living Inc. | 3.24B | -4.57% | 5,139,001 | 3.00B |
| 206 | WRBY | Warby Parker Inc. | 3.24B | -0.96% | 849,564 | 911.61M |
| 207 | ARQT | Arcutis Biotherapeutics, Inc. | 3.23B | 1.50% | 1,182,873 | 463.98M |
| 208 | QURE | uniQure N.V. | 3.21B | -0.45% | 645,814 | 18.67M |
| 209 | MBX | MBX Biosciences, Inc. | 3.17B | -2.86% | 187,139 | - |
| 210 | TMDX | TransMedics Group, Inc. | 3.03B | 4.02% | 892,489 | 668.47M |
| 211 | IRON | Disc Medicine, Inc. | 2.99B | 0.58% | 109,860 | - |
| 212 | PLSE | Pulse Biosciences, Inc. | 2.97B | -1.86% | 281,171 | 1.19M |
| 213 | ACHC | Acadia Healthcare Company, Inc. | 2.96B | 0.97% | 813,393 | 3.37B |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 2.94B | 3.47% | 499,336 | 606.33M |
| 215 | IOVA | Iovance Biotherapeutics, Inc. | 2.93B | 2.05% | 11,890,153 | 324.97M |
| 216 | IMNM | Immunome, Inc. | 2.89B | 1.84% | 846,828 | 4.02M |
| 217 | ALHC | Alignment Healthcare, Inc. | 2.87B | -3.62% | 2,972,449 | 4.58B |
| 218 | ABCL | AbCellera Biologics Inc. | 2.86B | 34.78% | 41,582,537 | 66.17M |
| 219 | PRVA | Privia Health Group, Inc. | 2.83B | -1.29% | 540,299 | 2.36B |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.75B | -0.67% | 400,170 | 830.44M |
| 221 | BEAM | Beam Therapeutics Inc. | 2.72B | -0.91% | 680,790 | 156.04M |
| 222 | KOD | Kodiak Sciences Inc. | 2.71B | -4.30% | 379,713 | - |
| 223 | ATAI | AtaiBeckley Inc. | 2.68B | 0.07% | 2,569,734 | 3.49M |
| 224 | NRIX | Nurix Therapeutics, Inc. | 2.67B | 0.67% | 447,269 | 36.77M |
| 225 | GRDN | Guardian Pharmacy Services, Inc. | 2.64B | -4.77% | 209,116 | 1.46B |
| 226 | RARE | Ultragenyx Pharmaceutical Inc. | 2.63B | 3.20% | 1,258,105 | 717.00M |
| 227 | ZLAB | Zai Lab Limited | 2.61B | -0.30% | 874,917 | 449.61M |
| 228 | VRDN | Viridian Therapeutics, Inc. | 2.61B | -2.29% | 1,316,134 | 71.13M |
| 229 | AXGN | Axogen, Inc. | 2.60B | 3.96% | 543,897 | 251.17M |
| 230 | BFLY | Butterfly Network, Inc. | 2.59B | 10.36% | 9,074,247 | 112.14M |
| 231 | RGC | Regencell Bioscience Holdings Limited | 2.59B | -3.42% | 150,604 | - |
| 232 | TRVI | Trevi Therapeutics, Inc. | 2.55B | -3.13% | 475,574 | - |
| 233 | HTFL | HeartFlow, Inc. | 2.55B | 2.71% | 496,942 | 191.42M |
| 234 | NKTR | Nektar Therapeutics | 2.52B | -2.38% | 234,514 | 55.63M |
| 235 | PBH | Prestige Consumer Healthcare Inc. | 2.52B | -3.03% | 303,069 | 1.10B |
| 236 | PGEN | Precigen, Inc. | 2.52B | -2.77% | 2,882,224 | 85.72M |
| 237 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.51B | -1.40% | 747,465 | -665.00K |
| 238 | NEOG | Neogen Corporation | 2.50B | -0.04% | 684,409 | 870.40M |
| 239 | UFPT | UFP Technologies, Inc. | 2.48B | 2.08% | 96,067 | 631.64M |
| 240 | CDNA | CareDx, Inc. | 2.47B | 2.38% | 750,818 | 458.09M |
| 241 | CLOV | Clover Health Investments, Corp. | 2.47B | -2.31% | 4,037,511 | 2.48B |
| 242 | PHVS | Pharvaris N.V. | 2.46B | 1.00% | 405,947 | - |
| 243 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.46B | 2.77% | 2,136,444 | 940.61M |
| 244 | KLRA | Kailera Therapeutics, Inc. | 2.41B | -0.24% | 102,394 | - |
| 245 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | -0.80% | 318,527 | - |
| 246 | BHC | Bausch Health Companies Inc. | 2.39B | 2.24% | 1,935,100 | 10.85B |
| 247 | XRAY | DENTSPLY SIRONA Inc. | 2.37B | -1.98% | 3,546,973 | 3.64B |
| 248 | COAG | Hemab Therapeutics Holdings, Inc. | 2.32B | 0.23% | 207,074 | - |
| 249 | WGS | GeneDx Holdings Corp. | 2.32B | 0.95% | 397,193 | 454.43M |
| 250 | NUVB | Nuvation Bio Inc. | 2.29B | -0.98% | 3,244,982 | 169.90M |
| 251 | HRMY | Harmony Biosciences Holdings, Inc. | 2.28B | 1.99% | 301,353 | 959.90M |
| 252 | VCEL | Vericel Corporation | 2.27B | -1.71% | 174,733 | 306.30M |
| 253 | VERA | Vera Therapeutics, Inc. | 2.27B | -3.95% | 551,668 | - |
| 254 | URGN | UroGen Pharma Ltd. | 2.25B | -1.79% | 363,891 | 188.73M |
| 255 | HCM | HUTCHMED (China) Limited | 2.23B | -0.28% | 17,027 | 549.12M |
| 256 | ESTA | Establishment Labs Holdings Inc. | 2.23B | -3.36% | 453,982 | 245.82M |
| 257 | RAPP | Rapport Therapeutics, Inc. | 2.22B | 1.87% | 135,819 | 20.00M |
| 258 | PVLA | Palvella Therapeutics, Inc. | 2.21B | -2.69% | 83,272 | - |
| 259 | SLS | SELLAS Life Sciences Group, Inc. | 2.21B | -6.58% | 3,694,321 | - |
| 260 | BHVN | Biohaven Ltd. | 2.20B | -0.34% | 546,675 | - |
| 261 | ADUS | Addus HomeCare Corporation | 2.20B | 0.27% | 81,105 | 1.48B |
| 262 | ADMA | ADMA Biologics, Inc. | 2.18B | -1.72% | 994,525 | 512.28M |
| 263 | PGNY | Progyny, Inc. | 2.17B | 0.68% | 653,143 | 1.31B |
| 264 | MESO | Mesoblast Limited | 2.17B | 4.45% | 198,774 | 65.38M |
| 265 | NEO | NeoGenomics, Inc. | 2.12B | -0.18% | 930,590 | 766.30M |
| 266 | ATRC | AtriCure, Inc. | 2.12B | 0.80% | 237,967 | 569.62M |
| 267 | SGRY | Surgery Partners, Inc. | 2.09B | 3.73% | 2,113,371 | 3.37B |
| 268 | STOK | Stoke Therapeutics, Inc. | 2.08B | -1.41% | 176,074 | 27.59M |
| 269 | MD | Pediatrix Medical Group, Inc. | 2.08B | -3.36% | 441,991 | 1.95B |
| 270 | TSHA | Taysha Gene Therapies, Inc. | 2.07B | -1.52% | 1,293,354 | 7.47M |
| 271 | AVAH | Aveanna Healthcare Holdings Inc. | 2.06B | -0.32% | 767,172 | 2.52B |
| 272 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | -2.46% | 587,670 | 311.51M |
| 273 | NVCR | NovoCure Limited | 2.03B | 6.59% | 585,443 | 699.19M |
| 274 | GHRS | GH Research PLC | 2.03B | -2.11% | 147,632 | - |
| 275 | ZBIO | Zenas BioPharma, Inc. | 2.03B | -0.83% | 179,845 | 10.00M |
| 276 | OCUL | Ocular Therapeutix, Inc. | 2.02B | 0.11% | 804,790 | 52.06M |
| 277 | NBTX | Nanobiotix S.A. | 1.96B | -3.95% | 124,198 | 38.27M |
| 278 | ALMR | Alamar Biosciences, Inc. | 1.94B | -1.58% | 134,596 | 87.16M |
| 279 | AGIO | Agios Pharmaceuticals, Inc. | 1.94B | 0.59% | 527,368 | 98.34M |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.91B | 1.36% | 451,139 | 481.22M |
| 281 | KARD | Kardigan, Inc. | 1.89B | 3.32% | 181,447 | - |
| 282 | FBRX | Forte Biosciences, Inc. | 1.88B | 0.04% | 560,919 | - |
| 283 | GENB | Generate Biomedicines, Inc. | 1.87B | 1.46% | 326,792 | 26.48M |
| 284 | ASTH | Astrana Health, Inc. | 1.85B | 4.82% | 302,137 | 3.84B |
| 285 | LMAT | LeMaitre Vascular, Inc. | 1.84B | -1.19% | 301,380 | 262.43M |
| 286 | BRVE | Braveheart Bio, Inc. | 1.84B | -4.67% | 292,904 | - |
| 287 | BCAX | Bicara Therapeutics Inc. | 1.82B | -1.14% | 681,123 | - |
| 288 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | -0.39% | 519,201 | 252.25M |
| 289 | DMRA | Damora Therapeutics, Inc. | 1.81B | -1.54% | 145,792 | - |
| 290 | FTRE | Fortrea Holdings Inc. | 1.80B | 2.69% | 473,619 | 2.68B |
| 291 | CMPS | COMPASS Pathways plc | 1.79B | -2.14% | 1,289,176 | - |
| 292 | SRPT | Sarepta Therapeutics, Inc. | 1.79B | 0.77% | 1,252,526 | 1.97B |
| 293 | LKFT | Lakefront Biotherapeutics NV | 1.78B | -0.50% | 103,203 | 1.20B |
| 294 | SEPN | Septerna, Inc. | 1.77B | 0.95% | 159,849 | 72.26M |
| 295 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | 1.71% | 9,604,335 | 54.86M |
| 296 | PRGO | Perrigo Company plc | 1.74B | -2.41% | 944,352 | 4.14B |
| 297 | INSP | Inspire Medical Systems, Inc. | 1.73B | -0.65% | 294,493 | 898.74M |
| 298 | IMCR | Immunocore Holdings plc | 1.73B | -0.12% | 152,157 | 430.78M |
| 299 | AAPG | Ascentage Pharma Group International | 1.70B | -0.76% | 3,239 | 82.08M |
| 300 | TRLV | Trulieve Cannabis Corp. | 1.70B | 0.91% | 465,791 | 1.14B |
| 301 | OMCL | Omnicell, Inc. | 1.70B | 0.95% | 282,054 | 1.25B |
| 302 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 1.01% | 1,832,449 | 59.51M |
| 303 | BLFS | BioLife Solutions, Inc. | 1.69B | -0.43% | 198,300 | 106.69M |
| 304 | ZYME | Zymeworks Inc. | 1.68B | 0.68% | 528,340 | 37.13M |
| 305 | TRAX | First Tracks Biotherapeutics, Inc. | 1.67B | 5.80% | 323,626 | - |
| 306 | AGL | agilon health, inc. | 1.67B | 4.14% | 288,140 | 5.92B |
| 307 | KMTS | Kestra Medical Technologies, Ltd. | 1.66B | 7.27% | 215,784 | 95.13M |
| 308 | ANAB | AnaptysBio, Inc. | 1.65B | -1.52% | 231,186 | 232.39M |
| 309 | ANIP | ANI Pharmaceuticals, Inc. | 1.65B | -1.73% | 339,612 | 978.38M |
| 310 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.59B | -1.44% | 1,213,468 | 208.78M |
| 311 | XNCR | Xencor, Inc. | 1.58B | 2.21% | 535,833 | 104.97M |
| 312 | ARDT | Ardent Health, Inc. | 1.58B | -3.64% | 241,482 | 6.41B |
| 313 | TNDM | Tandem Diabetes Care, Inc. | 1.57B | 0.85% | 1,199,186 | 1.04B |
| 314 | TYRA | Tyra Biosciences, Inc. | 1.56B | -1.36% | 202,134 | - |
| 315 | PSNL | Personalis, Inc. | 1.53B | 1.27% | 2,832,053 | 69.67M |
| 316 | ABSI | Absci Corporation | 1.52B | 0.34% | 2,143,573 | 1.84M |
| 317 | HCSG | Healthcare Services Group, Inc. | 1.52B | -0.54% | 349,708 | 1.86B |
| 318 | OMDA | Omada Health, Inc. | 1.52B | 4.69% | 1,785,282 | 309.76M |
| 319 | OBX | Obsidian Therapeutics, Inc. | 1.52B | 27.27% | 19,074 | - |
| 320 | VIR | Vir Biotechnology, Inc. | 1.51B | 0.85% | 823,583 | 303.23M |
| 321 | AVLN | Avalyn Pharma Inc. | 1.49B | -0.83% | 50,049 | - |
| 322 | CNMD | CONMED Corporation | 1.49B | 1.30% | 153,249 | 1.37B |
| 323 | INNV | InnovAge Holding Corp. | 1.49B | -1.88% | 90,121 | 949.17M |
| 324 | HROW | Harrow, Inc. | 1.49B | -1.38% | 350,414 | 268.68M |
| 325 | INVA | Innoviva, Inc. | 1.49B | 0.29% | 465,062 | 440.00M |
| 326 | MAZE | Maze Therapeutics, Inc. | 1.48B | -6.88% | 398,026 | 20.00M |
| 327 | AZTA | Azenta, Inc. | 1.46B | 3.84% | 532,007 | 613.81M |
| 328 | XERS | Xeris Biopharma Holdings, Inc. | 1.45B | 0.13% | 878,713 | 335.41M |
| 329 | ENOV | Enovis Corporation | 1.45B | -5.75% | 859,128 | 2.30B |
| 330 | AVBP | ArriVent BioPharma, Inc. | 1.44B | 0.32% | 258,664 | - |
| 331 | ATEC | Alphatec Holdings, Inc. | 1.44B | - | 869,285 | 815.05M |
| 332 | SVRA | Savara Inc. | 1.44B | -2.92% | 604,707 | - |
| 333 | PAHC | Phibro Animal Health Corporation | 1.41B | 1.34% | 105,710 | 1.50B |
| 334 | MLTX | MoonLake Immunotherapeutics | 1.41B | -6.68% | 2,867,463 | - |
| 335 | AMN | AMN Healthcare Services, Inc. | 1.40B | 0.75% | 455,968 | 3.43B |
| 336 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | -0.07% | 875,794 | - |
| 337 | SDGR | Schrödinger, Inc. | 1.39B | 2.42% | 770,532 | 259.04M |
| 338 | PNTG | The Pennant Group, Inc. | 1.39B | 1.78% | 125,038 | 1.10B |
| 339 | ALVO | Alvotech | 1.37B | 0.39% | 633,695 | 562.04M |
| 340 | NUTX | Nutex Health Inc. | 1.34B | 20.90% | 282,123 | 846.72M |
| 341 | GLUE | Monte Rosa Therapeutics, Inc. | 1.34B | -1.32% | 397,421 | 28.73M |
| 342 | AKTS | Aktis Oncology, Inc. | 1.33B | 0.04% | 143,925 | 8.28M |
| 343 | IART | Integra LifeSciences Holdings Corporation | 1.33B | -0.58% | 315,322 | 1.65B |
| 344 | IMTX | Immatics N.V. | 1.33B | 0.52% | 120,957 | 43.00M |
| 345 | FRNM | Freenome, Inc. | 1.32B | 4.66% | 524,095 | 34.24M |
| 346 | INBX | Inhibrx Biosciences, Inc. | 1.31B | 0.67% | 250,688 | 1.30M |
| 347 | LBRX | LB Pharmaceuticals Inc | 1.30B | -5.56% | 320,883 | - |
| 348 | AORT | Artivion, Inc. | 1.29B | -2.47% | 329,111 | 471.47M |
| 349 | GDRX | GoodRx Holdings, Inc. | 1.29B | 2.72% | 1,840,008 | 785.23M |
| 350 | NVAX | Novavax, Inc. | 1.29B | -1.89% | 2,151,313 | 413.80M |
| 351 | TDOC | Teladoc Health, Inc. | 1.29B | -0.70% | 1,840,058 | 2.49B |
| 352 | JBIO | Jade Biosciences, Inc. | 1.27B | -2.23% | 449,199 | - |
| 353 | STAA | STAAR Surgical Company | 1.26B | 4.13% | 515,459 | 290.38M |
| 354 | MNKD | MannKind Corporation | 1.25B | -5.11% | 2,685,521 | 393.63M |
| 355 | PRCT | PROCEPT BioRobotics Corporation | 1.25B | 6.91% | 1,103,823 | 337.34M |
| 356 | SPTX | Seaport Therapeutics, Inc. | 1.25B | -1.31% | 30,923 | - |
| 357 | VOR | Vor Biopharma Inc. | 1.25B | -2.79% | 341,506 | - |
| 358 | CERT | Certara, Inc. | 1.23B | -1.95% | 958,681 | 421.75M |
| 359 | USPH | U.S. Physical Therapy, Inc. | 1.21B | 1.21% | 112,453 | 804.27M |
| 360 | DRTS | Alpha Tau Medical Ltd. | 1.21B | 1.83% | 339,701 | - |
| 361 | MGTX | MeiraGTx Holdings plc | 1.21B | -0.15% | 114,715 | 79.76M |
| 362 | ETON | Eton Pharmaceuticals, Inc. | 1.20B | -1.46% | 202,376 | 86.93M |
| 363 | WVE | Wave Life Sciences Ltd. | 1.19B | -1.15% | 841,973 | 65.37M |
| 364 | AHG | Akso Health Group | 1.19B | 2.58% | 19,176 | 13.83M |
| 365 | BVS | Bioventus Inc. | 1.16B | -2.09% | 504,979 | 581.85M |
| 366 | IRMD | IRADIMED CORPORATION | 1.16B | -1.88% | 58,792 | 86.34M |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 1.16B | 1.58% | 366,007 | - |
| 368 | CRON | Cronos Group Inc. | 1.16B | -2.74% | 1,184,553 | 179.09M |
| 369 | IVA | Inventiva S.A. | 1.16B | -1.04% | 292,496 | 7.94M |
| 370 | LTGO | Latigo Biotherapeutics, Inc. | 1.15B | - | 497,664 | - |
| 371 | REPL | Replimune Group, Inc. | 1.14B | 12.44% | 7,218,401 | - |
| 372 | CRVS | Corvus Pharmaceuticals, Inc. | 1.14B | -2.80% | 578,464 | - |
| 373 | EYPT | EyePoint, Inc. | 1.13B | -5.54% | 986,777 | 2.79M |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | 0.60% | 200,626 | 1.03B |
| 375 | APMD | Apnimed, Inc. | 1.10B | 2.67% | 118,886 | 120.15M |
| 376 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.09B | -0.61% | 1,854,698 | 41.47M |
| 377 | ANRO | Alto Neuroscience, Inc. | 1.08B | -2.93% | 163,517 | - |
| 378 | SANA | Sana Biotechnology, Inc. | 1.07B | 1.56% | 1,506,693 | - |
| 379 | AVTX | Avalo Therapeutics, Inc. | 1.05B | 6.44% | 521,841 | 59.00K |
| 380 | OLMA | Olema Pharmaceuticals, Inc. | 1.04B | -0.83% | 326,456 | - |
| 381 | OPK | OPKO Health, Inc. | 1.03B | 1.09% | 1,562,023 | 587.90M |
| 382 | ODTX | Odyssey Therapeutics, Inc. | 1.03B | 1.70% | 42,859 | 99.00K |
| 383 | CSTL | Castle Biosciences, Inc. | 1.01B | 3.08% | 181,072 | 357.28M |
| 384 | JANX | Janux Therapeutics, Inc. | 1.00B | 3.34% | 384,769 | 24.00M |
| 385 | ARDX | Ardelyx, Inc. | 979.31M | -1.75% | 5,937,362 | 450.89M |
| 386 | GMRS | GMR Solutions Inc. | 979.17M | 0.16% | 115,426 | 5.83B |
| 387 | PCRX | Pacira BioSciences, Inc. | 976.62M | -2.08% | 361,321 | 746.16M |
| 388 | OMER | Omeros Corporation | 967.66M | 0.91% | 701,795 | 9.89M |
| 389 | GERN | Geron Corporation | 947.65M | -0.34% | 3,175,687 | 204.56M |
| 390 | QDEL | QuidelOrtho Corporation | 916.85M | 8.83% | 1,551,013 | 2.67B |
| 391 | SLDB | Solid Biosciences Inc. | 903.91M | 0.48% | 482,899 | - |
| 392 | ABUS | Arbutus Biopharma Corporation | 901.01M | -1.49% | 527,992 | 191.45M |
| 393 | COLL | Collegium Pharmaceutical, Inc. | 897.56M | -6.45% | 565,150 | 808.21M |
| 394 | AVR | Anteris Technologies Global Corp. | 888.79M | 2.36% | 318,694 | 1.85M |
| 395 | GLAS | Glass House Brands Inc. | 883.37M | -2.76% | 150,026 | 177.68M |
| 396 | DSGN | Design Therapeutics, Inc. | 879.59M | 0.46% | 275,052 | - |
| 397 | TBPH | Theravance Biopharma, Inc. | 875.12M | -0.27% | 211,078 | 104.31M |
| 398 | AMPH | Amphastar Pharmaceuticals, Inc. | 873.30M | -1.20% | 322,375 | 730.02M |
| 399 | ANNX | Annexon, Inc. | 873.28M | -1.48% | 1,218,499 | - |
| 400 | INMD | InMode Ltd. | 871.98M | -0.91% | 210,854 | 374.63M |
| 401 | TALK | Talkspace, Inc. | 867.26M | 0.19% | 479,564 | 245.73M |
| 402 | ACRS | Aclaris Therapeutics, Inc. | 867.00M | -0.34% | 1,084,084 | 8.22M |
| 403 | HSTM | HealthStream, Inc. | 858.19M | 2.19% | 108,639 | 321.12M |
| 404 | ATTO | Attovia Therapeutics, Inc. | 849.82M | -2.08% | 220,777 | 1.35M |
| 405 | KURA | Kura Oncology, Inc. | 848.68M | -0.10% | 523,584 | 71.64M |
| 406 | SIBN | SI-BONE, Inc. | 848.42M | 1.72% | 188,181 | 213.60M |
| 407 | AURA | Aura Biosciences, Inc. | 847.10M | -3.88% | 302,790 | - |
| 408 | SGP | SpyGlass Pharma, Inc. | 835.53M | -1.30% | 22,049 | - |
| 409 | DBVT | DBV Technologies S.A. | 795.72M | 4.60% | 368,311 | 5.04M |
| 410 | OCS | Oculis Holding AG | 789.86M | 0.91% | 145,878 | 1.45M |
| 411 | PHAR | Pharming Group N.V. | 785.51M | -2.60% | 5,017 | 366.48M |
| 412 | CLYM | Climb Bio, Inc. | 782.86M | -2.64% | 494,567 | - |
| 413 | DRUG | Bright Minds Biosciences Inc. | 781.58M | 1.41% | 91,720 | - |
| 414 | VREX | Varex Imaging Corporation | 777.81M | 48.71% | 11,269,983 | 865.00M |
| 415 | MNPR | Monopar Therapeutics Inc. | 773.91M | -3.09% | 248,078 | - |
| 416 | CADL | Candel Therapeutics, Inc. | 772.27M | -0.47% | 416,672 | - |
| 417 | PHR | Phreesia, Inc. | 765.23M | -1.04% | 254,514 | 495.59M |
| 418 | RIGL | Rigel Pharmaceuticals, Inc. | 764.94M | 1.94% | 115,093 | 276.79M |
| 419 | SSII | SS Innovations International, Inc. | 760.50M | 0.80% | 14,490 | 48.47M |
| 420 | FTH | Faeth Therapeutics, Inc. | 757.12M | 20.13% | 191,850 | - |
| 421 | EVO | Evotec SE | 750.67M | 4.49% | 46,566 | 859.03M |
| 422 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 749.00M | 0.21% | 89,316 | - |
| 423 | BBNX | Beta Bionics, Inc. | 745.93M | 4.28% | 923,893 | 119.01M |
| 424 | AGMB | AgomAb Therapeutics NV | 740.20M | 3.66% | 60,772 | - |
| 425 | CTMX | CytomX Therapeutics, Inc. | 739.77M | -1.88% | 800,325 | 18.30M |
| 426 | CBLL | CeriBell, Inc. | 735.33M | 3.03% | 253,924 | 95.07M |
| 427 | CBIO | Crescent Biopharma, Inc. | 727.19M | 0.89% | 140,467 | 11.88M |
| 428 | NGNE | Neurogene Inc. | 720.36M | 1.29% | 126,739 | 925.00K |
| 429 | ALLO | Allogene Therapeutics, Inc. | 717.92M | 3.48% | 3,793,253 | 22.00K |
| 430 | SLN | Silence Therapeutics plc | 715.12M | 26.69% | 14,497,373 | 615.00K |
| 431 | AHCO | AdaptHealth Corp. | 705.07M | -7.12% | 4,398,820 | 3.36B |
| 432 | GYRE | Gyre Therapeutics, Inc. | 704.06M | -0.45% | 34,625 | 109.82M |
| 433 | IMMX | Immix Biopharma, Inc. | 697.51M | 0.31% | 1,141,776 | - |
| 434 | RGNX | REGENXBIO Inc. | 687.20M | -2.89% | 575,750 | 174.48M |
| 435 | ACHV | Achieve Life Sciences, Inc. | 686.79M | 0.60% | 505,873 | - |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 674.18M | -5.56% | 1,519,182 | 389.32M |
| 437 | ZVRA | Zevra Therapeutics, Inc. | 673.41M | -1.90% | 418,381 | 136.07M |
| 438 | PHAT | Phathom Pharmaceuticals, Inc. | 673.17M | -0.88% | 1,257,164 | 239.66M |
| 439 | TCMD | Tactile Systems Technology, Inc. | 667.89M | 0.37% | 165,039 | 343.52M |
| 440 | ANGO | AngioDynamics, Inc. | 649.33M | 0.13% | 273,293 | 320.17M |
| 441 | SOPH | SOPHiA GENETICS SA | 642.72M | -2.08% | 326,044 | 86.17M |
| 442 | HELP | Cybin Inc. | 635.96M | -11.63% | 2,171,000 | - |
| 443 | BWAY | BrainsWay Ltd. | 630.64M | -0.77% | 33,035 | 56.22M |
| 444 | TECX | Tectonic Therapeutic, Inc. | 621.77M | 2.66% | 65,007 | - |
| 445 | MDXG | MiMedx Group, Inc. | 620.94M | -1.84% | 543,747 | 355.17M |
| 446 | STLN | Starling Oncology, Inc. | 620.67M | -4.99% | 1,451,446 | 587.24M |
| 447 | NVCT | Nuvectis Pharma, Inc. | 614.49M | -0.47% | 95,211 | - |
| 448 | KIDS | OrthoPediatrics Corp. | 606.01M | 1.93% | 139,402 | 252.72M |
| 449 | VSTM | Verastem, Inc. | 592.28M | -2.97% | 1,259,926 | 87.53M |
| 450 | TLRY | Tilray Brands, Inc. | 591.28M | -4.60% | 2,661,116 | 915.45M |
| 451 | ALT | Altimmune, Inc. | 587.31M | -1.95% | 3,222,888 | 36.00K |
| 452 | CRMD | CorMedix Inc. | 585.25M | 0.27% | 434,075 | 400.05M |
| 453 | ARVN | Arvinas, Inc. | 580.96M | 1.54% | 360,592 | 316.70M |
| 454 | SPRY | ARS Pharmaceuticals, Inc. | 580.92M | -5.03% | 813,202 | 98.99M |
| 455 | CTEV | Claritev Corporation | 579.60M | 4.94% | 97,160 | 994.67M |
| 456 | CTKB | Cytek Biosciences, Inc. | 577.13M | 5.71% | 464,067 | 206.71M |
| 457 | SGMT | Sagimet Biosciences Inc. | 576.14M | 2.98% | 1,327,358 | - |
| 458 | FDMT | 4D Molecular Therapeutics, Inc. | 574.52M | 2.23% | 323,558 | 88.24M |
| 459 | DCTH | Delcath Systems, Inc. | 563.16M | 7.41% | 914,225 | 95.42M |
| 460 | PRME | Prime Medicine, Inc. | 560.40M | 2.27% | 2,556,797 | 4.07M |
| 461 | AQST | Aquestive Therapeutics, Inc. | 555.82M | 12.44% | 5,868,316 | 50.27M |
| 462 | AUTL | Autolus Therapeutics plc | 554.91M | -1.18% | 2,032,307 | 92.62M |
| 463 | CTNM | Contineum Therapeutics, Inc. | 554.54M | -1.99% | 228,161 | - |
| 464 | STTK | Shattuck Labs, Inc. | 552.87M | -0.83% | 619,805 | 1.00M |
| 465 | MPLT | MapLight Therapeutics, Inc. | 551.86M | - | 333,512 | - |
| 466 | ARTV | Artiva Biotherapeutics, Inc. | 542.68M | -1.51% | 96,629 | 251.00K |
| 467 | ZURA | Zura Bio Limited | 537.69M | -5.11% | 790,021 | - |
| 468 | EIKN | Eikon Therapeutics, Inc. | 525.96M | 4.57% | 291,975 | - |
| 469 | FLGT | Fulgent Genetics, Inc. | 522.24M | -0.84% | 128,915 | 323.93M |
| 470 | ANL | Adlai Nortye Ltd. | 519.20M | -2.26% | 115,117 | 5.00M |
| 471 | DNA | Ginkgo Bioworks Holdings, Inc. | 519.19M | -3.26% | 1,003,407 | 132.42M |
| 472 | BIOA | BioAge Labs, Inc. | 518.64M | -3.58% | 347,731 | 10.36M |
| 473 | SRTA | Strata Critical Medical, Inc. | 516.20M | 0.78% | 718,547 | 255.98M |
| 474 | ASMB | Assembly Biosciences, Inc. | 514.58M | 0.19% | 51,643 | 71.10M |
| 475 | EVMN | Evommune, Inc. | 510.09M | -0.18% | 139,228 | 10.00M |
| 476 | NPCE | NeuroPace, Inc. | 505.78M | 0.03% | 132,972 | 99.53M |
| 477 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 478 | PROK | ProKidney Corp. | 499.91M | 0.91% | 879,671 | 889.00K |
| 479 | CERS | Cerus Corporation | 497.77M | 5.11% | 1,330,721 | 221.55M |
| 480 | VALN | Valneva SE | 496.81M | - | 44,377 | 180.25M |
| 481 | ENTX | Entera Bio Ltd. | 491.72M | -1.05% | 211,932 | 42.00K |
| 482 | BLSM | BlossomHill Therapeutics, Inc. | 490.60M | 0.06% | 279,326 | - |
| 483 | RLMD | Relmada Therapeutics, Inc. | 490.15M | -6.98% | 1,212,357 | - |
| 484 | RZLT | Rezolute, Inc. | 486.82M | -0.64% | 349,908 | - |
| 485 | KYTX | Kyverna Therapeutics, Inc. | 485.15M | 0.25% | 285,632 | - |
| 486 | OABI | OmniAb, Inc. | 484.15M | 8.12% | 1,254,082 | 38.46M |
| 487 | PRLD | Prelude Therapeutics Incorporated | 482.99M | -0.61% | 146,037 | 16.72M |
| 488 | OVID | Ovid Therapeutics Inc. | 476.87M | -2.85% | 503,815 | 7.12M |
| 489 | IKT | Inhibikase Therapeutics, Inc. | 476.83M | -1.21% | 329,469 | 1.00 |
| 490 | EOLS | Evolus, Inc. | 475.23M | -5.20% | 604,662 | 316.49M |
| 491 | QTTB | Q32 Bio Inc. | 469.76M | 1.15% | 282,422 | 53.74M |
| 492 | BNTC | Benitec Biopharma Inc. | 461.72M | -1.39% | 40,331 | - |
| 493 | NRC | NRC Health | 456.55M | 1.47% | 62,436 | 140.00M |
| 494 | PBYI | Puma Biotechnology, Inc. | 455.29M | -1.01% | 242,234 | 231.24M |
| 495 | EVH | Evolent Health, Inc. | 455.06M | 1.90% | 1,983,553 | 2.10B |
| 496 | SCTX | Scribe Therapeutics Inc. | 454.25M | -7.38% | 77,569 | 36.28M |
| 497 | PRTA | Prothena Corporation plc | 452.28M | 0.57% | 273,910 | 54.53M |
| 498 | CABA | Cabaletta Bio, Inc. | 450.85M | -0.90% | 1,755,218 | - |
| 499 | CLPT | ClearPoint Neuro, Inc. | 444.75M | 2.60% | 279,016 | 42.28M |
| 500 | EPRX | Eupraxia Pharmaceuticals Inc. | 443.40M | -0.74% | 103,471 | - |